Skip to main content
. 2022 Feb 10;24(4):415–426. doi: 10.1007/s11912-022-01228-w

Fig. 1.

Fig. 1

Schematic representation of factors reported to be associated with TFR or molecular relapse, including immune cell subtypes (in blue) and other molecular factors (in orange)